Marty Makary, President Trump’s choice to lead the Food and Drug Administration, has resigned from the post under mounting pressure. His departure comes after weeks of internal conflict with the administration.
The decision was finalized on Tuesday. Makary had privately voiced opposition to a key policy move by the White House.
Makary disagreed with the administration’s plan to approve flavored vapes for sale. His stance created a rift with other officials and political appointees.
The agency’s top food official will now take over Makary’s responsibilities. This transition is effective immediately, according to administration sources.
Makary was a controversial figure from the start. His appointment faced scrutiny from public health advocates and some senators.
The resignation highlights ongoing tensions within the FDA. Disagreements over policy direction have become more frequent in recent months.
Flavored vapes have been a divisive issue in public health circles. Experts warn they appeal strongly to teenagers and young adults.
The administration has argued the decision supports adult smokers who seek alternatives. Critics say it undermines years of anti-smoking progress.
Makary’s exit leaves a leadership gap at the agency. The incoming acting commissioner will face immediate pressure to address the vaping policy.
